Classification of CHF with EF 20-25%
An ejection fraction of 20-25% definitively classifies the patient as having Heart Failure with Reduced Ejection Fraction (HFrEF), which corresponds to ACC/AHA Stage C heart failure. The NYHA functional class cannot be determined by ejection fraction alone—it depends entirely on the patient's current symptoms and functional limitations 1.
Understanding the Classification Systems
ACC/AHA Stage Classification
With an EF of 20-25%, this patient has Stage C heart failure by definition, as they have structural heart disease with reduced ejection fraction 1. Stage C specifically indicates "structural heart disease with prior or current symptoms of HF" 1.
- Stage A: At risk but no structural disease or symptoms
- Stage B: Structural disease but no symptoms
- Stage C: Structural disease with prior or current symptoms (this patient)
- Stage D: Refractory HF requiring specialized interventions
NYHA Functional Class - Symptom-Based Assessment
The NYHA class is completely independent of ejection fraction and must be determined by assessing the patient's functional capacity 1:
- Class I: No limitation of physical activity; ordinary activity does not cause HF symptoms
- Class II: Slight limitation; comfortable at rest, but ordinary activity causes symptoms
- Class III: Marked limitation; comfortable at rest, but less than ordinary activity causes symptoms
- Class IV: Unable to perform any activity without symptoms, or symptoms at rest
Critical Clinical Considerations
Why EF Doesn't Determine NYHA Class
Research demonstrates substantial overlap in objective measures across NYHA classes 2. Patients with severely reduced EF (20-25%) can range from asymptomatic (Class I) to severely symptomatic (Class IV). The evidence shows:
- Mortality varies significantly even within the same NYHA class across different populations 2
- There is 60-88% overlap in objective measures (NT-proBNP, 6-minute walk distance) between NYHA Class I and II patients 3, 2
- Peak oxygen consumption is a more reliable predictor of prognosis than NYHA class alone 4
Practical Assessment Algorithm
To determine NYHA class for this patient with EF 20-25%:
Ask about dyspnea with ordinary activities (walking, climbing stairs, household tasks)
- No symptoms → Class I
- Symptoms with ordinary activity → Class II
- Symptoms with minimal activity → Class III
- Symptoms at rest → Class IV
Assess functional capacity objectively if classification is uncertain:
- 6-minute walk test distance
- NT-proBNP levels (though overlap exists between classes)
- Patient self-assessment using Visual Analogue Scale 3
Treatment Implications
This severely reduced EF (20-25%) mandates aggressive guideline-directed medical therapy (GDMT) regardless of NYHA class 5, 6:
- ACE inhibitors or ARNIs
- Beta-blockers (carvedilol, metoprolol succinate, or bisoprolol)
- Mineralocorticoid receptor antagonists (aldosterone antagonists) - specifically indicated for LVEF ≤35% 5, 6
- SGLT2 inhibitors
- Diuretics for volume management
Device therapy consideration: With EF 20-25%, the patient likely qualifies for ICD evaluation if they are NYHA Class II-III on optimal medical therapy 7.
Common Pitfall
Do not assume severe LV dysfunction (EF 20-25%) automatically means severe symptoms. Some patients with this degree of systolic dysfunction remain minimally symptomatic (NYHA Class I-II), while others are severely limited (Class III-IV). The classification systems serve different purposes: ACC/AHA stages track disease progression and structural changes, while NYHA class guides symptom management and device eligibility 1.